The U.S. is experiencing events that are either the first stages of a widespread avian influenza outbreak or a fire drill that will show how well the nation is prepared for an outbreak. The U.S. has not stepped up to meet the challenge, Rick Bright, the former director of BARDA, told BioCentury.In an interview with The BioCentury Show's Steve Usdin, Bright said there are opportunities for biotech companies to help fill voids in surveillance, point-of-care diagnostics, vaccines and therapeutics. The federal government must provide leadership and funding to unleash industry, but it has acted slowly and hasn’t taken the necessary initiative, Bright said.View full story: https://www.biocentury.com/article/652676#biotech #biopharma #pharma #lifescience #politics #policy #law00:00 - Intro01:56 - H5N1: State of Play10:14 - Rebuilding Trust, Vaccines20:50 - Creating Better Therapeutics25:34 - BARDA, Barriers to Preparedness32:50 – Urgent Next Steps

Ver todos los episodios